Kaveri Seed Company Ltd Q1 FY2026 Concall Summary

Key Takeaways

• Non-cotton strength offset by cotton drag: Revenue grew on higher non-cotton acreages and realizations, but illegal cotton seeds and cost pressures pulled overall EBITDA margins down ~1%.
• Non-cotton segment targets ~20% sustained growth: Driven by acreage expansion in maize and the rice market shifting toward hybrids, with pricing power intact to pass on cost increases.
• Cotton recovery delayed, not derailed: New product mix jumped from 12% to 34% of cotton volumes, and management expects good cotton growth, just pushed out by a year.
• Inventory built aggressively, write-off risk flagged but dismissed: Inventory rose ~40% YoY to capture a strong season and avoid last year's stock-out; management sees all inventory as new and low-risk, though returns are not yet fully known.
• What to watch next quarter: Whether the 20% full-year growth trajectory materializes as the second half unfolds, the pace of cotton margin recovery, and any clarity on the consolidated vs standalone sales gap that management could not explain on the call.

Non-Cotton: The Growth Engine

• Rice and maize led the quarter: Increased volumes of non-cotton hybrids delivered good realizations, well reflected in overall revenue growth. Hybrid rice grew despite sowing restrictions in Punjab, and maize volumes rose more than 21%.
• Pricing power intact outside cotton: Cost of production rose across most crops, but the company successfully passed those costs to farmers in the non-cotton segment. Cotton prices, by contrast, are restricted by government and weighed down by inventory.
• Revenue growth outpacing volume growth: The trend of substantially higher revenue growth relative to volume growth across rice, maize, and vegetables is expected to continue in coming years.
• Rice market still mostly varietal: Rice acreage increased 17% but the gain moved to varieties, not hybrids; the company maintained and increased its share within the hybrid segment with 6% volume growth.
• Pipeline filling white spaces: Very good pipeline hybrids are coming for the southern maize segment, and the company is working on rice and maize segments where it is not currently present.

Mithun Chand: "Definitely, what we think is that non-cotton segment should be in and around the 20% growth levels going forward as we see acreage increase in maize. And even we see the rice market to go up."

Cotton: A Temporary Setback

• Illegal seeds and cost inflation hit profitability: Cotton sales were impacted by an increase in illegal BG-II RRF seeds and a rise in the cost of production of cotton seed, which dragged overall EBITDA margins down ~1%.
• New product mix is the bridge to recovery: Contributions from new cotton products (launched in the last two years) rose from 12% to 34% of volumes. Management targets 80% to 90% of cotton revenue from new products by FY28.
• The illegal-seed problem is industry-wide: Tens of smaller Indian companies produce illegal cotton seeds. The industry association has represented to authorities that this will harm farmers and yields, and management expects the situation will be corrected.
• Margin drag seen as temporary: All companies produced more cotton seed this year, inflating inventory and competition. Management expects production to moderate, easing the margin pressure.
• BG-III approval awaited: Continuous dialogue with approving authorities is ongoing; approval could come any time, but no firm timeline was given.

Mithun Chand: "And that's a very temporary thing. This year, all the companies have produced more. Now it should moderate."

Margins & Cost Structure

• Cotton pulled margins down, non-cotton pulled them up: Non-cotton segment margins improved, but the cotton drag resulted in an overall EBITDA margin dip of ~1% compared to the prior year.
• Cost of production outlook is benign: After a year of aggressive production and high competition that drove up costs, inventories are now ample and companies are slowing production. Management sees no significant further rise in cost inflation over the next 2 to 3 years.
• Depreciation run rate steady: ₹12-15 crores per quarter is expected for the next 5 to 6 quarters, after which it should taper off.
• Margins expected to improve going forward: With cost pressures moderating and non-cotton growth sustaining, the trajectory should turn favorable.

Mithun Chand: "I don't see any like further rise in some sort of inflation here, but not a significant rise as like what we have witnessed this year that we may not witness in the coming next 2 to 3 years."

Inventory & Balance Sheet

• Intentional inventory build of ~40% YoY: The company increased inventory anticipating a good season and wanting to maintain buffer stock after facing an inventory crunch and losing sales last year.
• Write-off risk acknowledged but downplayed: Management stated all inventory is new and sees no high risk of writing it off currently, but noted that stock has not yet been returned and only a provision has been made.
• Industry returns are elevated: Other companies may show different results because they take 10-15% returns policy while Kaveri treats only liquidated stock as sale and provides everything as returns; this season, industry returns are higher than usual terms.

Subsidiaries, Exports & Adjacent Businesses

• Subsidiary sales explain the consolidated gap: Consolidated sales are lower than standalone because most subsidiaries are cotton-only and inter-company sales are eliminated. For example, if ₹800 is sold in cotton through a subsidiary, ₹600 is registered in Kaveri books and only ₹200 in subsidiary books. Management could not fully clarify the accounting treatment on the call and promised to follow up.
• Subsidiaries diversifying beyond cotton: Subsidiaries previously concentrated only on cotton; they are now moving into non-cotton segments, which come in the second half, so subsidiary business should be much better than last year.
• Export growth of 30-40% expected: Positivity in Bangladesh, Tanzania, Vietnam, and the Philippines supports a meaningful export uplift compared to the previous year.
• Crop nutrients a small but growing adjacency: The crop nutrients business is currently ₹45-50 crores, housed in subsidiaries, and is expected to see good growth over the next 3 to 5 years with a pan-India product and network presence in a year or two.

Guidance & Commitments

Key Metrics